135 related articles for article (PubMed ID: 15368518)
41. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
Williams MV; Holliday J; Glaser R
Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
[TBL] [Abstract][Full Text] [Related]
42. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
43. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.
Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R
PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
Dutta N; Gupta A; Mazumder DN; Banerjee S
Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
47. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
49. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
51. The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway.
Ariza ME; Glaser R; Kaumaya PT; Jones C; Williams MV
J Immunol; 2009 Jan; 182(2):851-9. PubMed ID: 19124728
[TBL] [Abstract][Full Text] [Related]
52. Chronic Physical Stress Does Not Interact with Epstein-Barr Virus (EBV)-Encoded Dutpase to Alter the Sickness Response.
Aubrecht TG; Weil ZM; Abi Salloum B; Ariza ME; Williams M; Reader B; Glaser R; Sheridan J; Nelson RJ
J Behav Brain Sci; 2015 Oct; 5(11):513-523. PubMed ID: 27175311
[TBL] [Abstract][Full Text] [Related]
53. Peripheral blood lymphocytes express recombination-activating genes 1 and 2 during Epstein-Barr virus-induced infectious mononucleosis.
Wagner HJ; Scott RS; Buchwald D; Sixbey JW
J Infect Dis; 2004 Sep; 190(5):979-84. PubMed ID: 15295705
[TBL] [Abstract][Full Text] [Related]
54. An Overview of Epstein-Barr Virus: from Discovery to Future Directions for Treatment and Prevention.
Andersson J
Herpes; 2000 Oct; 7(3):76-82. PubMed ID: 11867007
[TBL] [Abstract][Full Text] [Related]
55. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.
Halpin P; Williams MV; Klimas NG; Fletcher MA; Barnes Z; Ariza ME
J Med Virol; 2017 Sep; 89(9):1636-1645. PubMed ID: 28303641
[TBL] [Abstract][Full Text] [Related]
56. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
57. [The transfection and morphological changes of human embryonic nasopharyngeal epithelia infected by Epstein-Barr virus cooperated with promoter in vitro and in vivo].
Sun N; Chen X; Wu F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):70-3. PubMed ID: 12515178
[TBL] [Abstract][Full Text] [Related]
58. Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events.
Binkley PF; Cooke GE; Lesinski A; Taylor M; Chen M; Laskowski B; Waldman WJ; Ariza ME; Williams MV; Knight DA; Glaser R
PLoS One; 2013; 8(1):e54008. PubMed ID: 23349778
[TBL] [Abstract][Full Text] [Related]
59. [Regulation and evasion of host immune responses by Epstein-Barr virus].
Xiao N; Chen Q; Cai S
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):19-25. PubMed ID: 27305776
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus-encoded deoxyuridine triphosphate nucleotidohydrolase (dUTPase): a potential target for drug therapy.
Kremmer E; Sommer P; Grässer FA
Transplant Proc; 1997; 29(1-2):812-4. PubMed ID: 9123537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
